Kyorin Pharmaceutical Licenses KRP-M223 to Novartis for Global Development
CompanyDeals

Kyorin Pharmaceutical Licenses KRP-M223 to Novartis for Global Development

GSK's Depemokimab Accepted for FDA Review as Ultra-Long-Acting Biologic
CompanyDrug

GSK’s Depemokimab Accepted for FDA Review as Ultra-Long-Acting Biologic

Juvestar and Raziel Therapeutics Launch Phase III Study for RZL-012 in China
CompanyDrug

Juvestar and Raziel Therapeutics Launch Phase III Study for RZL-012 in China

Waters and Kehua's LC-MS Systems Gain NMPA Approval for IVD Use
CompanyMedical Device

Waters and Kehua’s LC-MS Systems Gain NMPA Approval for IVD Use

Zai Lab's Augtyro Receives TFDA Approval for ROS1-Positive NSCLC and NTRK Fusion Solid Tumors
CompanyDrug

Zai Lab’s Augtyro Receives TFDA Approval for ROS1-Positive NSCLC and NTRK Fusion Solid Tumors

Shanghai BioScience Completes RMB 100M Financing Round Led by HUAGAI Capital
CompanyDeals

Shanghai BioScience Completes RMB 100M Financing Round Led by HUAGAI Capital

Bayer HealthCare and JD Healthcare Partner on Women's Health Ecosystem
CompanyDeals

Bayer HealthCare and JD Healthcare Partner on Women’s Health Ecosystem

Huadong Medicine's HDM1005 Receives NMPA Approval for Clinical Trials
CompanyDrug

Huadong Medicine’s HDM1005 Receives NMPA Approval for Clinical Trials

Bio-heart's Iberis RDN System Completes First Commercial Surgery in Germany
CompanyMedical Device

Bio-heart’s Iberis RDN System Completes First Commercial Surgery in Germany

Geneseeq and MGI Tech Form Global Partnership for Oncology Solutions
CompanyDeals

Geneseeq and MGI Tech Form Global Partnership for Oncology Solutions

Tonghua Dongbao's Tongboli Under GMP Inspection in Egypt
CompanyDrug

Tonghua Dongbao’s Tongboli Under GMP Inspection in Egypt

United Laboratories' UBT251 Receives FDA Green Light for Phase II CKD Study
CompanyDrug

United Laboratories’ UBT251 Receives FDA Green Light for Phase II CKD Study